Cingulate Inc.

NASDAQ:CING

Biotechnology

Healthcare
$5.11 -0.95%

-$0.05 today

Market cap
$76.46M
Beta
-0.91
P/E (TTM)
-1.0
EPS (TTM)
-$5.10
52W Low $3.16High $11.89

Volume 0.95M

Average 0.46M

CING EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How CING compares with its peers on the latest reported figures

No competitor EBITDA Margin figures are available to compare.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development8.41M9M15.49M9.45M9.77M
Selling, General & Admin12.27M8.51M7.27M6.2M10.16M
Operating Expenses20.68M17.5M22.76M15.64M19.94M
Depreciation & Amortization708.32K394.01K582.92K653.09K540.89K
EBITDA(19.97M)(17.11M)(22.18M)(14.99M)(19.4M)
EBITDA Margin—————
Operating Income(20.68M)(17.5M)(22.76M)(15.64M)(19.94M)
Operating Margin—————
Interest Income0175775.76K0369.27K
Interest Expense33.41K174K00924.45K
Other Income / Expenses(30.59K)(174.51K)(775.76K)(914.63K)(2.51M)
Income Before Tax(20.71M)(17.68M)(23.53M)(16.56M)(22.45M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(20.71M)(17.68M)(23.53M)(16.56M)(22.45M)
Net Margin—————
EPS (Basic)(55.80)(31.20)(311.99)(10.20)(4.13)
EPS (Diluted)(55.80)(31.20)(311.99)(10.20)(4.13)
Weighted Avg Shares1.41M1.41M2.26M3.81M5.43M
Weighted Avg Shares (Diluted)1.41M1.41M2.26M3.81M5.43M

Cingulate Inc.

NASDAQ:CING

Intrinsic Alpha fair value

Locked

Current Price

$5.11

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.